Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Vera Therapeutics, Inc. per 2025 Jun 30 adalah -236.05 MM.
- Nilai net income untuk Vera Therapeutics, Inc. per 2025 Jun 30 adalah -218.28 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -236.05 | -218.28 | |
2025-03-31 | -193.25 | -175.46 | |
2024-12-31 | -167.17 | -152.15 | |
2024-09-30 | -145.28 | -134.38 | |
2024-06-30 | -117.24 | -107.85 | |
2024-03-31 | -101.87 | -94.30 | |
2023-12-31 | -102.01 | -95.99 | |
2023-09-30 | -108.56 | -102.77 | |
2023-06-30 | -112.05 | -107.35 | |
2023-03-31 | -105.14 | -102.04 | |
2022-12-31 | -90.90 | -89.06 | |
2022-09-30 | -73.91 | -73.46 | |
2022-06-30 | -55.91 | -56.40 | |
2022-03-31 | -46.71 | -44.98 | |
2021-12-31 | -34.40 | -32.61 | |
2021-09-30 | -58.80 | -58.64 | |
2021-06-30 | -54.17 | -55.49 | |
2021-03-31 | -51.49 | -55.65 | |
2020-12-31 | -49.24 | -53.41 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -3.00 | -3.00 |
2024-12-31 | -2.75 | |
2024-09-30 | -2.62 | -2.62 |
2024-06-30 | -2.22 | -2.22 |
2024-03-31 | -2.05 | -2.05 |
2023-12-31 | -2.25 | |
2023-09-30 | -2.67 | -2.67 |
2023-06-30 | -3.14 | -3.14 |
2023-03-31 | -3.41 | -3.41 |
2022-12-31 | -3.35 | |
2022-09-30 | -2.94 | -2.94 |
2022-06-30 | -2.40 | -2.40 |
2022-03-31 | -2.32 | -2.32 |
2021-12-31 | -2.43 | |
2021-09-30 | -7.17 | -7.17 |
2021-06-30 | -19.17 | -19.17 |
2021-03-31 | -165.20 | -165.20 |
2020-12-31 | -166.93 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Vera Therapeutics, Inc. per 2025 Jun 30 adalah -185.27 MM.
- Nilai cash from investing activities untuk Vera Therapeutics, Inc. per 2025 Jun 30 adalah -139.21 MM.
- Nilai kas dari aktivitas pendanaan untuk Vera Therapeutics, Inc. per 2025 Jun 30 adalah 348.51 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -185.27 | -139.21 | 348.51 |
2025-03-31 | -155.25 | -190.43 | 331.67 |
2024-12-31 | -134.68 | -425.03 | 606.67 |
2024-09-30 | -120.64 | -185.09 | 305.55 |
2024-06-30 | -106.73 | -207.18 | 305.10 |
2024-03-31 | -99.72 | -270.95 | 302.10 |
2023-12-31 | -92.18 | -39.43 | 133.54 |
2023-09-30 | -88.20 | -44.55 | 129.42 |
2023-06-30 | -83.65 | -63.22 | 130.03 |
2023-03-31 | -84.91 | -18.86 | 129.65 |
2022-12-31 | -67.60 | -70.55 | 101.93 |
2022-09-30 | -52.87 | -88.99 | 86.14 |
2022-06-30 | -39.94 | -86.55 | 85.24 |
2022-03-31 | -28.57 | -43.66 | 134.18 |
2021-12-31 | -23.71 | -4.20 | 53.88 |
2021-09-30 | -44.65 | 0.85 | 128.76 |
2021-06-30 | -41.62 | 0.85 | 128.67 |
2021-03-31 | -36.62 | 0.01 | 80.30 |
2020-12-31 | -34.81 | -0.04 | 85.29 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Vera Therapeutics, Inc. pada 2025 Jun 30 adalah 2.81.
- p/tbv untuk Vera Therapeutics, Inc. pada 2025 Jun 30 adalah 2.81.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 2.81 | 2.81 | |
2025-03-31 | -11.16 | 2.94 | 2.94 |
2024-12-31 | 9.21 | 9.21 | |
2024-09-30 | -22.08 | 7.26 | 7.26 |
2024-06-30 | -20.10 | 5.36 | 5.36 |
2024-03-31 | -23.97 | 22.63 | 22.63 |
2023-12-31 | -6.65 | 5.52 | 5.52 |
2023-09-30 | |||
2023-06-30 | -7.73 | 5.00 | 5.00 |
2023-03-31 | -3.85 | 4.46 | |
2022-12-31 | 5.06 | 5.06 | |
2022-09-30 | 4.76 | 4.76 | |
2022-06-30 | -8.25 | 2.76 | 2.76 |
2022-03-31 | -18.86 | 8.84 | 8.84 |
2021-12-31 | -9.67 | 6.64 | 6.64 |
2021-09-30 | -6.66 | 4.01 | 4.01 |
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Vera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.18.
- EBIT (3 tahun) / EV untuk Vera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.14.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.18 | -0.14 |
2025-03-31 | -0.14 | -0.10 |
2024-12-31 | -0.06 | -0.05 |
2024-09-30 | -0.05 | -0.05 |
2024-06-30 | -0.06 | -0.05 |
2024-03-31 | -0.04 | -0.03 |
2023-12-31 | -0.19 | -0.14 |
2023-09-30 | ||
2023-06-30 | -0.15 | -0.11 |
2023-03-31 | -0.35 | -0.25 |
2022-12-31 | -0.17 | -0.10 |
2022-09-30 | -0.11 | -0.07 |
2022-06-30 | -0.17 | -0.14 |
2022-03-31 | -0.06 | -0.06 |
2021-12-31 | -0.12 | -0.09 |
2021-09-30 | -0.20 | -0.07 |
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 |
Efektivitas Manajemen
- roa untuk Vera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.44.
- roe untuk Vera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.54.
- roic untuk Vera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.30.
- croic untuk Vera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.02.
- ocroic untuk Vera Therapeutics, Inc. pada 2025 Jun 30 adalah -0.26.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.44 | -0.54 | -0.30 | -0.02 | -0.26 |
2025-03-31 | -0.36 | -0.43 | -0.24 | 0.07 | -0.21 |
2024-12-31 | -0.77 | -1.32 | -0.39 | -0.00 | -0.35 |
2024-09-30 | -0.61 | -0.87 | -0.28 | -0.02 | -0.28 |
2024-06-30 | -0.45 | -0.60 | -0.23 | -0.17 | -0.25 |
2024-03-31 | -0.73 | -1.25 | -0.62 | 0.01 | -0.59 |
2023-12-31 | -0.78 | -0.97 | -0.67 | -0.02 | -0.58 |
2023-09-30 | -0.72 | -0.88 | -0.63 | -0.10 | -0.49 |
2023-06-30 | -0.69 | -0.84 | -0.63 | -0.10 | -0.49 |
2023-03-31 | -0.54 | -0.66 | -0.54 | 0.14 | -0.45 |
2022-12-31 | -0.81 | -0.86 | -0.62 | -0.47 | -0.45 |
2022-09-30 | -0.62 | -0.66 | -0.62 | -0.47 | -0.45 |
2022-06-30 | -0.46 | -0.49 | -0.42 | -0.31 | -0.30 |
2022-03-31 | -0.63 | -0.70 | -0.31 | 0.42 | -0.19 |
2021-12-31 | -1.07 | -1.17 | -0.47 | 0.37 | -0.52 |
2021-09-30 | -15.64 | -0.69 | 0.99 | -0.45 | |
2021-06-30 | -10.31 | -15.64 | -0.60 | 0.95 | -0.45 |
2021-03-31 | -10.34 | -15.69 | -1.20 | 0.94 | -0.79 |
2020-12-31 | -9.93 | -15.06 | -1.06 | 1.00 | -0.69 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1831828 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |